« Previous Next » Journal of Vascular Surgery
Volume 45, Issue 6 , Pages 1109-1113 , June 2007

Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm

Anders Wanhainen, MD, PhD
- Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Uppsala, Sweden
- Correspondence: Dr Anders Wanhainen, Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, SE-371 85 Uppsala, Sweden.
Torbjörn K. Nilsson, MD, PhD
- Department of Clinical Chemistry, Örebro University Hospital, Uppsala, Sweden
David Bergqvist, MD, PhD
- Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Uppsala, Sweden
Kurt Boman, MD, PhD
- Department of Medicine, Skellefteå County Hospital, Uppsala, Sweden
- Institution of Public Health and Clinical Medicine, Umeå University Hospital, Uppsala, Sweden.
Martin Björck, MD, PhD
- Department of Surgical Sciences, Section of Vascular Surgery, Uppsala University Hospital, Uppsala, Sweden

Received 25 September 2006 ,Accepted 4 February 2007.

Overview of the fibrinolytic system. tPA, Tissue plasminogen activator; uPA, urokinase-type plasminogen activator; PAI-1, plasminogen activator inhibitor-1.

Overview of the fibrinolytic system. tPA, Tissue plasminogen activator; uPA, urokinase-type plasminogen activator; PAI-1, plasminogen activator inhibitor-1.
- Full-Size Image
- Download to PowerPoint
Overview of the study design. VIP, Västerbotten Intervention Program; tPA-PAI; tissue plasminogen activator; PAI, plasminogen activator inhibitor; AAA, abdominal aortic aneurysm.

Overview of the study design. VIP, Västerbotten Intervention Program; tPA-PAI; tissue plasminogen activator; PAI, plasminogen activator inhibitor; AAA, abdominal aortic aneurysm.
- Full-Size Image
- Download to PowerPoint